The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

Abstract Introduction An Alzheimer's disease (AD) biomarker adjusted for age‐related brain changes should improve specificity for AD‐related pathological burden. Methods We calculated a brain‐age‐adjusted “personalized AD cortical thickness index” (pADi) in mild cognitive impairment patients fr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Annie M. Racine, Michael Brickhouse, David A. Wolk, Bradford C. Dickerson, Alzheimer's Disease Neuroimaging Initiative
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wiley 2018-01-01
Saila:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Gaiak:
AD index
AD signature
Alzheimer's disease
Cortical thickness
Mild cognitive impairment
Sarrera elektronikoa:https://doi.org/10.1016/j.dadm.2018.02.007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak